Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusiness

Zydus Cadila gets USFDA nod for generic cholesterol drug

The Ahmedabad-based group has received final approval from the US Food and Drug Administration (USFDA) to market the drug in the strengths of 10 mg, 20 mg, 40 mg and 80 mg, Zydus Cadila said in a statement.

November 22, 2018 / 03:37 PM IST
Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug maker Zydus Cadila on Thursday said it has received approval from the US health regulator to market cholesterol-lowering drug Atorvastatin Calcium tablets.

The Ahmedabad-based group has received final approval from the US Food and Drug Administration (USFDA) to market the drug in the strengths of 10 mg, 20 mg, 40 mg and 80 mg, Zydus Cadila said in a statement.

The product will be manufactured at its formulations facility at Moraiya, Ahmedabad, it added.

Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins.

Zydus Cadila said it has also received a tentative approval for Dimethyl Fumarate Delayed-Release Capsules, which is indicated for the treatment of relapsing forms of multiple sclerosis.

Shares of Cadila Healthcare, the listed entity of the group, were trading 1.47 percent down at Rs 353 per unit on the BSE.

PTI
first published: Nov 22, 2018 03:32 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347